HKSE:02509 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:02509 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Qyuns Therapeutics Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0. Qyuns Therapeutics Co's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is HK$0.00.
As of today (2025-01-18), Qyuns Therapeutics Co's share price is HK$6.71. Qyuns Therapeutics Co's Median PS Value is HK$0.00. Therefore, Qyuns Therapeutics Co's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Qyuns Therapeutics Co's Median PS Value or its related term are showing as below:
The historical data trend for Qyuns Therapeutics Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qyuns Therapeutics Co Annual Data | |||||||
Trend | Dec21 | Dec22 | Dec23 | ||||
Median PS Value | - | - | - |
Qyuns Therapeutics Co Quarterly Data | ||||||||
Dec21 | Sep22 | Dec22 | Jun23 | Sep23 | Dec23 | Jun24 | ||
Median PS Value | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, Qyuns Therapeutics Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Qyuns Therapeutics Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Qyuns Therapeutics Co's Price-to-Median-PS-Value falls into.
Qyuns Therapeutics Co's Median PS Value for today is calculated as
Median PS Value | = | Revenue per Share (TTM) | * | 10-Year Median PS Ratio |
= | 0 | * | ||
= | 0.00 |
10-Year Median PS Ratio is .
Qyuns Therapeutics Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qyuns Therapeutics Co (HKSE:02509) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Qyuns Therapeutics Co's Price to Median PS Value for today is calculated as
Price to Median PS Value | = | Share Price | / | Median PS Value |
= | 6.71 | / | 0.00 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Qyuns Therapeutics Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Zhu Jing | ||
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership) | ||
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Qing Dao Xin Chen Ke Chuang Shi Ye You Xian Gong Si | ||
Zi Jin Xin Tuo You Xian Ze Ren Gong Si | ||
Tai Zhou Hua Cheng Yi Xue Tou Zi Ji Tuan You Xian Gong Si | ||
Nan Jing Zi Jin Tou Zi Ji Tuan You Xian Ze Ren Gong Si | ||
Nan Jing Shi Guo You Zi Chan Tou Zi Guan Li Kong Gu Ji Tuan You Xian Ze Ren Gong Si | ||
Bei Jing Hong Tai Tong Chuang Tou Zi Guan Li You Xian Gong Si | ||
Sheng Xi Tai | ||
Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Hu Kaijun | 2201 Interest of corporation controlled by you | |
Yu Guo'an | ||
Hangzhou Quanyi Investment Management Partnership (general Partnership) |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.